Item 9 Labs Corp. has appointed Andrew Bowden to its board.
Bowden serves as co-founder and CEO of Bowden Investment Group, an investment firm.
Scottsdale, Ariz.-based Item 9 Labs develops, manufactures and distributes nasal breathing devices.
Item 9 Labs adds director
Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge
COVID-19 Impact & Recovery: Private Equity
COVID-19 Impact & Recovery: Corporates
COVID-19 Impact & Recovery: Investment Banking
Item 9 Labs adds director
- Author Hassan Aftab
- Theme Healthcare & Pharmaceuticals
- Author
- Hassan Aftab
- Theme
- Healthcare & Pharmaceuticals